If you need any product or service please register as the Farmavita.Net network member and publish your needs.
License-in is very cost effective way of product development. In the most of the licensing cases you will pay only share of total development cost for the pharmaceutical product.
Published license-out opportunities are alphabetically listed according to pharmaceutical INN name.
Please choose the category below:
1
Member of Farmavita:net offer Dossier and license for Epoprostenol
CTD with supply agreement and marketing authorization
Epoprostenol 0.5 mg and 1.5 mg (Powder and Solvent for Solution for Infusion)
Epoprostenol is indicated for:
Pulmonary Arterial HypertensionEpoprostenol is indicated for the treatment of pulmonary arterial hypertension (PAH) (idiopathic or heritable PAH and PAH ociated with connective tissue diseases) in...
1
Member of Farmavita.Net offer Faviravir Dossier with supply:
Favipravir 200 mg tablet (40 tablet / box)
API source: DMF (China or India) / GMP facility
Finished dose facility: Turkey / EU GMP
First marketing authorisation: Turkey
Dossier: EU CTD with supply agreeement
1
Sildenafil 100 mg gel, patented formulation.
1 box: 4 sachet x 5gr
API source: CEP(İndia) / GMP facility
Finished dose facility: Turkey / EU GMP
First marketing authorisation: Turkey
Dossier: EU CTD with supply agreeement
Member of Farmavita.net is offering dossier in European CTD format for Ibuprofen, 600 mg, sachets.
Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions....
There is on-going development of generic EU CTD Dossier of Escitalopram, tablets. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
Farmavita.Net members, from India, are offering license-out of formulation documentation for more than two hundred (200) pharmaceutical products. Each CTDossier is available for lump sum payment, without supply obligation. This Dossiers does not include clincal studies.
Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product.
It is expected that buyer of...
Member of Farmavita.net is offering dossier in European CTD format for Anastrazole, 1 mg, tablets.
Dossier is authorised in EU. Masrting authorisation transfer is available. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Anastrazole is classified as antineoplastic medicine, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this...
Farmavita.Net member has developed technology which enables development of oral dosage forms with controlled and site specific release of active pharmaceutical ingredients. Patent pending application.
Company is looking for following types of cooperation: - Out-licensing - Joint-venture and private equity partners - Collaborative product development - Consulting or contract research contracts
Description of technology: - the...
License-out offer for 6-APA API technology
Member of Farmavita.net offers know-how for fermentation process for manufacture of active pharmaceutical ingredient of 6 APA. Know how is available as non-exclusive license with lump sum payment. Payment is made after yield and quality of API is confirmed in the laboratory. Guarantied process parameters are:
6-APA
Intermediate
6-AMINOPENICILLANIC...
Member of Farmavita.net is offering dossier in European CTD format forZopiclone, 3,75/7,5 mg; tablets.
Dossier is registered in The Netherlands.
License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with...
There is on-going development of generic EU CTD Dossier of Zolmitriptan, tablets and mouth dissolving tablets, 2.5/5 mg.
DCP slot confirmed.
Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
Zolmitriptan is a...
Member of Farmavita.net is offering dossier in European CTD format for Zeledronic acid, 4 mg, lyophilized powder for injection.
Dossier is under development. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Zeledronic acid is classified as an antineoplastic, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out...
Member of Farmavita.net is offering dossier in European CTD format for Vinorelbine, 10 mg/ml as 10 – 50 mg solution, solution for injection.
Dossier is ready, not submitted. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Vinorelbine is classified as an antineoplastic, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is...
Member of Farmavita.net is offering dossier in European CTD format for Venlafaxine XR, 37,5 – 75 – 150 mg, XR capsules.
Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Venlafaxine XR is classified as a nervous system medicine, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this...
There is on-going development of generic EU CTD Dossier of Valsartan and Valsartan+HCTZ, tablets. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
Valsartan is a nonpeptide, orally active, and specific...
UK MA's for Sale: Ibuprofen 400 mg tablets and Paracetamol 500 mg tablets UK MA's for sale
Instant transfer of ownership, manufacturing site transfer allowed. Please write in at bd@pharmnertia.com
Member of Farmavita.net is offering dossier in European CTD format for Triamterene/HCTZ; 50/25 mg, tablets.
Dossier is registered in The Netherlands.
License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Triamterene/HCTZ is classified as a cardiovascular system medicine, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried...
Member of Farmavita.net is offering dossier in European CTD format for Triamterene/Epitiazide; 50/4 mg, capsules.
Dossier is registered in The Netherlands.
License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Triamterene/Epitiazide is classified as a cardiovascular system medicine, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical...
Member of Farmavita.net is offering dossier in European CTD format for Triamterene; 50 mg, tablets.
Dossier is registered in The Netherlands.
License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Triamterene is classified as a cardiovascular system medicine, according ATC index.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according...
Member of Farmavita.net is offering dossier in European CTD format for Torfenamide; 60 mg, tablets.
Dossier is registered in The Netherlands.
License for use of Dossier is related to initial downpayment and commitment to bulk purchase.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions....